---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-335092"
form_type: "8-K"
ticker: "SGHT"
cik: "0001531177"
company_name: "Sight Sciences, Inc."
filed_at: "2026-08-05T20:09:46+00:00"
generated_at: "2026-08-05T20:12:00.275972+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Sight Sciences Q2 revenue $23.4M (+20% YoY); raises FY2026 revenue guidance to $88-92M

## Summary
- Q2 revenue $23.4M (+20% YoY); IG $20.7M (+8%), IDE record $2.7M (+704%).
- Net loss improved to $4.4M ($0.08 loss per share) from $11.9M ($0.23) YoY.
- Raised FY2026 revenue guidance to $88-92M (prior $83-89M); reduced adjusted opex guidance to $92-94M.
- Cash usage $5.2M in Q2, down 28% YoY; cash $79.8M; debt $40M.
- FDA 510(k) clearance for OMNI Ultra; Aetna coverage for implant-free glaucoma procedures.

## SEC filing metadata
- accession: 0001193125-26-335092
- form_type: 8-K
- ticker: SGHT
- cik: 0001531177
- company_name: Sight Sciences, Inc.
- filed_at: 2026-08-05T20:09:46+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1531177/000119312526335092/0001193125-26-335092-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1531177/000119312526335092/sght-20260805.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-335092
- JSON: https://secwatch.observer/filing/0001193125-26-335092.json
- Plain text: https://secwatch.observer/filing/0001193125-26-335092.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.